EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Intrapartum Azithromycin vs Placebo for Neonatal Sepsis

Wan-Jie Gu, Jun Lyu, Hai-Yan Yin

JAMA · 2023

DOI: 10.1001/jama.2023.8328 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2023. Verfasst von Wan-Jie Gu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Azithromycin, Neonatal Sepsis, Anti-Bacterial Agents. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinNeonatal SepsisAnti-Bacterial AgentsHumansInfant, NewbornFemalePregnancyPeripartum Period

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Intensive Care Unit, First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Department of Clinical Research, First Affiliated Hospital of Jinan University, Guangzhou, China.

Zitieren

APA

Gu, W. J., Lyu, J., & Yin, H. Y. (2023). Intrapartum Azithromycin vs Placebo for Neonatal Sepsis. JAMA. https://doi.org/10.1001/jama.2023.8328

Vancouver

Gu WJ, Lyu J, Yin HY. Intrapartum Azithromycin vs Placebo for Neonatal Sepsis. JAMA. 2023. doi:10.1001/jama.2023.8328

BibTeX
@article{Gu2023,
  author = {Gu, Wan-Jie and Lyu, Jun and Yin, Hai-Yan},
  title = {Intrapartum Azithromycin vs Placebo for Neonatal Sepsis},
  journal = {JAMA},
  year = {2023},
  doi = {10.1001/jama.2023.8328}
}
Kostenlos starten →